BioInfra Co., Ltd. (KOSDAQ:199730)
5,640.00
-10.00 (-0.18%)
At close: Aug 13, 2025, 3:30 PM KST
BioInfra Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Net Income | -4,236 | -3,976 | 2,002 | 6,237 | 6,234 | 4,191 | Upgrade
|
Depreciation & Amortization | 3,380 | 3,316 | 2,388 | 1,980 | 1,180 | 941.23 | Upgrade
|
Loss (Gain) From Sale of Assets | - | - | -0.05 | -903.7 | -33.04 | 0.78 | Upgrade
|
Loss (Gain) From Sale of Investments | 716.38 | 716.38 | 135.17 | - | - | 0.32 | Upgrade
|
Loss (Gain) on Equity Investments | -0.44 | -1.86 | -138.5 | -24.79 | 209.88 | - | Upgrade
|
Stock-Based Compensation | -0.14 | - | 510.5 | 816.8 | 306.3 | - | Upgrade
|
Provision & Write-off of Bad Debts | 172.86 | 107.1 | 82.45 | 4.85 | -180.76 | 99.07 | Upgrade
|
Other Operating Activities | -2,439 | -1,905 | -1,109 | 610.29 | 817.59 | -593.86 | Upgrade
|
Change in Accounts Receivable | -481.21 | 866.07 | 158.68 | 594.96 | -2,812 | -32.8 | Upgrade
|
Change in Accounts Payable | -172.06 | -29.81 | -737.29 | 739.41 | 1,200 | -804.07 | Upgrade
|
Change in Income Taxes | -78.53 | -77.38 | -20.73 | - | - | - | Upgrade
|
Change in Other Net Operating Assets | -437.01 | 2,714 | -2,591 | -1,630 | -359.31 | 369.35 | Upgrade
|
Operating Cash Flow | -3,574 | 1,729 | 679.3 | 8,425 | 6,563 | 4,171 | Upgrade
|
Operating Cash Flow Growth | - | 154.55% | -91.94% | 28.36% | 57.35% | -3.66% | Upgrade
|
Capital Expenditures | -1,478 | -2,800 | -3,074 | -10,531 | -14,122 | -2,269 | Upgrade
|
Sale of Property, Plant & Equipment | - | - | 0.52 | - | 323.72 | - | Upgrade
|
Sale (Purchase) of Intangibles | -45.85 | -70.61 | -623.33 | -346.39 | -303.32 | -51.55 | Upgrade
|
Investment in Securities | -2,708 | -2,700 | -6,999 | 217.81 | -802.8 | -5.8 | Upgrade
|
Other Investing Activities | - | - | 0 | 10,538 | - | - | Upgrade
|
Investing Cash Flow | -4,232 | -5,571 | -10,696 | -121.44 | -14,904 | -2,327 | Upgrade
|
Short-Term Debt Issued | - | - | - | - | 3,567 | 2,800 | Upgrade
|
Long-Term Debt Issued | - | 4,200 | - | 4,000 | 11,600 | 1,533 | Upgrade
|
Total Debt Issued | 6,700 | 4,200 | - | 4,000 | 15,167 | 4,333 | Upgrade
|
Short-Term Debt Repaid | - | - | - | -2,800 | -4,527 | -1,500 | Upgrade
|
Long-Term Debt Repaid | - | -4,590 | -203.15 | -7,916 | -3,692 | -584.4 | Upgrade
|
Total Debt Repaid | -4,617 | -4,590 | -203.15 | -10,716 | -8,218 | -2,084 | Upgrade
|
Net Debt Issued (Repaid) | 2,083 | -390.36 | -203.15 | -6,716 | 6,948 | 2,249 | Upgrade
|
Issuance of Common Stock | 198.89 | 448.9 | 13,552 | - | - | - | Upgrade
|
Dividends Paid | -2,878 | -2,878 | - | - | - | - | Upgrade
|
Other Financing Activities | -0 | - | -0 | -6.6 | -0 | - | Upgrade
|
Financing Cash Flow | -596.65 | -2,820 | 13,349 | -6,723 | 6,948 | 2,249 | Upgrade
|
Miscellaneous Cash Flow Adjustments | -0 | -0 | 0 | -0 | 0 | 0 | Upgrade
|
Net Cash Flow | -8,403 | -6,661 | 3,332 | 1,580 | -1,393 | 4,093 | Upgrade
|
Free Cash Flow | -5,053 | -1,071 | -2,395 | -2,107 | -7,559 | 1,902 | Upgrade
|
Free Cash Flow Growth | - | - | - | - | - | 13.08% | Upgrade
|
Free Cash Flow Margin | -20.83% | -4.49% | -7.95% | -5.95% | -24.74% | 9.70% | Upgrade
|
Free Cash Flow Per Share | -1039.14 | -220.97 | -509.75 | -510.36 | -1830.82 | 1382.29 | Upgrade
|
Cash Interest Paid | 366.69 | 362.23 | 409.36 | 341.53 | 171.76 | 90.81 | Upgrade
|
Cash Income Tax Paid | 18.11 | 18.11 | 342.89 | 144.74 | 66.09 | 2.14 | Upgrade
|
Levered Free Cash Flow | -3,542 | 846.51 | -4,172 | -4,977 | -9,793 | 1,391 | Upgrade
|
Unlevered Free Cash Flow | -3,306 | 1,082 | -3,905 | -4,746 | -9,654 | 1,474 | Upgrade
|
Change in Working Capital | -1,169 | 3,472 | -3,190 | -296.12 | -1,971 | -467.52 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.